Browse result page of Hmrbase2
This is the result page of the browse module of Hmrbase2. This page gives the information about the query submitted by the user as per the browse category. Further details of the entries can be seen by clicking on the ID. Further the user can sort the entries on the basis of various fields by clicking on the respective headers. The user can also download the results in various formats.
| ID | Pubchem ID | Name | Description | Synonym | Molecular Weight | Formula | IUPAC | SMILE | PDB ID | Melting Point | Water Solubility | Receptor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20549 | 53481604 | Somatostatin fragment 3-14 | Somatostatin (also known as growth hormone-inhibiting hormone (GHIH) or somatotropin release-inhibiting factor (SRIF)) is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G-protein-coupled somatostatin receptors and inhib | Cys-lys-asn-phe-phe-TRP-lys-THR-phe-THR-ser-cys;(5S;8R;11R;14R;20R;23R;26R;29R;32R;35R;38R)-38-Amino-20;35-bis(4-aminobutyl)-14;26;29-tribenzyl-7;10;13;16;19;22;25;28;31;34;37-undecahydroxy-32-[(C-hyd | 1523.776 | C72H98N16O17S2 | (5S;8R;11R;14R;20R;23R;26R;29R;32R;35R;38R)-38-amino-20;35-bis(4-aminobutyl)-14;26;29-tribenzyl-32-(carbamoylmethyl)-17-(1-hydroxyethyl)-11-[(1S)-1-hydroxyethyl]-8-(hydroxymethyl)-23-[(1H-indol-3-yl)methyl]-7;10;13;16;19;22;25;28;31;34;37-undecaoxo-1;2-dithia-6;9;12;15;18;21;24;27;30;33;36-undecaazacyclononatriacontane-5-carboxylic acid | CC(O)C1NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)CSSCC[C@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC1=O)[C@H](C)O)C(O)=O | NA | NA | NA | NA| 20550 | 53481605 | Somatostatin | Somatostatin belongs to the class of organic compounds known as polypeptides. These are peptides containing ten or more amino acid residues. In humans; somatostatin is involved in the pancreas function - delta cell pathway. Somatostatin is a primary metabolite. Primary metabolites are metabolically | Growth hormone-inhibiting hormone (ghih);Somatotropin release-inhibiting factor (srif);Somatotropin release-inhibiting hormone;(5S;8R;14R;17R;20R;23R;26R;29R;32R;35R)-38-[(2-{[(2R)-2-amino-1-hydroxypr | 1651.905 | C77H106N18O19S2 | (5S;8R;14R;17R;20R;23R;26R;29R;32R;35R)-20;35-bis(4-aminobutyl)-38-{2-[(2R)-2-aminopropanamido]acetamido}-14;26;29-tribenzyl-32-(carbamoylmethyl)-11-(1-hydroxyethyl)-17-[(1S)-1-hydroxyethyl]-8-(hydroxymethyl)-23-[(1H-indol-3-yl)methyl]-7;10;13;16;19;22;25;28;31;34;37-undecaoxo-1;2-dithia-6;9;12;15;18;21;24;27;30;33;36-undecaazacyclononatriacontane-5-carboxylic acid | C[C@H](O)[C@H]1NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC(=O)C(CSSCC[C@H](NC(=O)[C@@H](CO)NC(=O)C(NC(=O)[C@@H](CC2=CC=CC=C2)NC1=O)C(C)O)C(O)=O)NC(=O)CNC(=O)[C@@H](C)N | NA | NA | NA | P31391; P35346; P30872; P32745; P30874; P30937; P30938; O08858; P30936; P30875; P30935; P28646; P30680 | 20559 | 25077649 | Nafarelin | Nafarelin is only found in individuals that have used or taken this drug. It is a potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis. | Nafarelin acetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoacetate;Nafarelin acetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoacetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoa | 1322.4713 | C66H83N17O13 | N-(5-carbamimidamido-1-{2-[(carbamoylmethyl)carbamoyl]pyrrolidin-1-yl}-1-oxopentan-2-yl)-2-{2-[2-(3-hydroxy-2-{2-[3-(1H-imidazol-4-yl)-2-[(5-oxopyrrolidin-2-yl)formamido]propanamido]-3-(1H-indol-3-yl)propanamido}propanamido)-3-(4-hydroxyphenyl)propanamido]-3-(naphthalen-2-yl)propanamido}-4-methylpentanamide | CC(C)CC(NC(=O)C(CC1=CC2=CC=CC=C2C=C1)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CNC=N1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCNC(N)=N)C(=O)N1CCCC1C(=O)NCC(N)=O | NA | NA | 0.017 g/L | NA | 20583 | 90470904 | Leptin | Implicated in the regulation of food intake; energy expenditure and whole-body energy balance↵↵Although leptin is a circulating signal that reduces appetite; in general; obese people have an unusually high circulating concentration of leptin. | NA | 2004.31 | C87H138N22O28S2 | (3S)-3-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-[(2-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-1-hydroxyethylidene)amino]-1;3-dihydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-carboxy-1-hydroxypropylidene]amino}-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-{[(1S)-1-{[(2S)-1-[(2S)-2-[({[(1R)-1-carboxy-2-sulfanylethyl]-C-hydroxycarbonimidoyl}methyl)-C-hydroxycarbonimidoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]-C-hydroxycarbonimidoyl}-3-methylbutyl]-C-hydroxycarbonimidoyl}propanoic acid | [H][C@](N)(CC(C)C)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=NCC(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=N[C@@]([H])(CC(O)=O)C(O)=N[C@@]([H])(CCSC)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CC(O)=O)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CO)C(=O)N1CCC[C@@]1([H])C(O)=NCC(O)=N[C@@]([H])(CS)C(O)=O | NA | NA | NA | P48357; Q62959; P48356; O02671; Q9MYL0 | 20644 | 53481604 | Somatostatin fragment 3-14 | Somatostatin (also known as growth hormone-inhibiting hormone (GHIH) or somatotropin release-inhibiting factor (SRIF)) is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G-protein-coupled somatostatin receptors and inhib | Cys-lys-asn-phe-phe-TRP-lys-THR-phe-THR-ser-cys;(5S;8R;11R;14R;20R;23R;26R;29R;32R;35R;38R)-38-Amino-20;35-bis(4-aminobutyl)-14;26;29-tribenzyl-7;10;13;16;19;22;25;28;31;34;37-undecahydroxy-32-[(C-hyd | 1523.776 | C72H98N16O17S2 | (5S;8R;11R;14R;20R;23R;26R;29R;32R;35R;38R)-38-amino-20;35-bis(4-aminobutyl)-14;26;29-tribenzyl-32-(carbamoylmethyl)-17-(1-hydroxyethyl)-11-[(1S)-1-hydroxyethyl]-8-(hydroxymethyl)-23-[(1H-indol-3-yl)methyl]-7;10;13;16;19;22;25;28;31;34;37-undecaoxo-1;2-dithia-6;9;12;15;18;21;24;27;30;33;36-undecaazacyclononatriacontane-5-carboxylic acid | CC(O)C1NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](N)CSSCC[C@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC1=O)[C@H](C)O)C(O)=O | NA | NA | NA | NA | 20645 | 53481605 | Somatostatin | Somatostatin belongs to the class of organic compounds known as polypeptides. These are peptides containing ten or more amino acid residues. In humans; somatostatin is involved in the pancreas function - delta cell pathway. Somatostatin is a primary metabolite. Primary metabolites are metabolically | Growth hormone-inhibiting hormone (ghih);Somatotropin release-inhibiting factor (srif);Somatotropin release-inhibiting hormone;(5S;8R;14R;17R;20R;23R;26R;29R;32R;35R)-38-[(2-{[(2R)-2-amino-1-hydroxypr | 1651.905 | C77H106N18O19S2 | (5S;8R;14R;17R;20R;23R;26R;29R;32R;35R)-20;35-bis(4-aminobutyl)-38-{2-[(2R)-2-aminopropanamido]acetamido}-14;26;29-tribenzyl-32-(carbamoylmethyl)-11-(1-hydroxyethyl)-17-[(1S)-1-hydroxyethyl]-8-(hydroxymethyl)-23-[(1H-indol-3-yl)methyl]-7;10;13;16;19;22;25;28;31;34;37-undecaoxo-1;2-dithia-6;9;12;15;18;21;24;27;30;33;36-undecaazacyclononatriacontane-5-carboxylic acid | C[C@H](O)[C@H]1NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC(=O)C(CSSCC[C@H](NC(=O)[C@@H](CO)NC(=O)C(NC(=O)[C@@H](CC2=CC=CC=C2)NC1=O)C(C)O)C(O)=O)NC(=O)CNC(=O)[C@@H](C)N | NA | NA | NA | P31391; P35346; P30872; P32745; P30874; P30937; P30938; O08858; P30936; P30875; P30935; P28646; P30680 | 20654 | 25077649 | Nafarelin | Nafarelin is only found in individuals that have used or taken this drug. It is a potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis. [PubChem]Li | Nafarelin acetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoacetate;Nafarelin acetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoacetate;Nafarelin acetate; hydrate;Synarel;Nafarelin monoa | 1322.4713 | C66H83N17O13 | N-(5-carbamimidamido-1-{2-[(carbamoylmethyl)carbamoyl]pyrrolidin-1-yl}-1-oxopentan-2-yl)-2-{2-[2-(3-hydroxy-2-{2-[3-(1H-imidazol-4-yl)-2-[(5-oxopyrrolidin-2-yl)formamido]propanamido]-3-(1H-indol-3-yl)propanamido}propanamido)-3-(4-hydroxyphenyl)propanamido]-3-(naphthalen-2-yl)propanamido}-4-methylpentanamide | CC(C)CC(NC(=O)C(CC1=CC2=CC=CC=C2C=C1)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CNC=N1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCNC(N)=N)C(=O)N1CCCC1C(=O)NCC(N)=O | NA | NA | 0.017 g/L | NA | 20679 | 90470904 | Leptin | Implicated in the regulation of food intake; energy expenditure and whole-body energy balance | NA | 2004.31 | C87H138N22O28S2 | (3S)-3-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-[(2-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-1-hydroxyethylidene)amino]-1;3-dihydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-carboxy-1-hydroxypropylidene]amino}-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-{[(1S)-1-{[(2S)-1-[(2S)-2-[({[(1R)-1-carboxy-2-sulfanylethyl]-C-hydroxycarbonimidoyl}methyl)-C-hydroxycarbonimidoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]-C-hydroxycarbonimidoyl}-3-methylbutyl]-C-hydroxycarbonimidoyl}propanoic acid | [H][C@](N)(CC(C)C)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=NCC(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=N[C@@]([H])(CC(O)=O)C(O)=N[C@@]([H])(CCSC)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CC(O)=O)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CO)C(=O)N1CCC[C@@]1([H])C(O)=NCC(O)=N[C@@]([H])(CS)C(O)=O | NA | NA | NA | P48357; Q62959; P48356; O02671; Q9MYL0 | |